ROYAL PHARMA 2011 LIMITED — Ceftriaxone Importer Profile
Pharmaceutical Importer · #1 buyer for Ceftriaxone · $2.9M import value · 226 shipments · KENYA · DGFT Verified
ROYAL PHARMA 2011 LIMITED is the #1 importer of Ceftriaxone from India with $2.9M in import value and 226 verified shipments. ROYAL PHARMA 2011 LIMITED holds a 2.4% market share in Ceftriaxone imports based in KENYA. The company sources from 3 verified suppliers across 123 formulations shipped to 2 countries. Overall, ROYAL PHARMA 2011 LIMITED imports 2 pharmaceutical products worth $8.4M across 2 therapeutic categories.
ROYAL PHARMA 2011 LIMITED — Ceftriaxone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ceftriaxone to ROYAL PHARMA 2011 LIMITED?
Verified from 226 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INNOVA CAPTAB LIMITED | $2.7M | 220 | 94.2% |
| EAST AFRICAN INDIA OVERSEAS | $141.6K | 4 | 4.9% |
| SAKAR HEALTHCARE LIMITED | $25.8K | 2 | 0.9% |
ROYAL PHARMA 2011 LIMITED sources Ceftriaxone from 3 verified Indian suppliers based on 226 customs records. The primary supplier is INNOVA CAPTAB LIMITED accounting for 94.2% of imports.
How Does ROYAL PHARMA 2011 LIMITED Compare to Nearest Ceftriaxone Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ROYAL PHARMA 2011 LIMITED ★ | KENYA | $6.8M | 135 | $50.0K |
| 5 | AUROVIDA FARMACEUTICA, SA DE CV, | MEXICO | $4.8M | 96 | $50.0K |
| 8 | AL JABAL DRUGS & MEDICAL APPLIANCES | YEMEN | $3.8M | 184 | $20.4K |
ROYAL PHARMA 2011 LIMITED ranks #1 among 2,555 Ceftriaxone importers from India. Average shipment value of $50.0K compared to the market average of $12.6K. The closest competitors by value are AUROVIDA FARMACEUTICA, SA DE CV, and AL JABAL DRUGS & MEDICAL APPLIANCES.
Where Does ROYAL PHARMA 2011 LIMITED Import Ceftriaxone To?
Destination countries from 226 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $2.8M | 214 | 97.8% |
| UGANDA | $63.8K | 12 | 2.2% |
ROYAL PHARMA 2011 LIMITED imports Ceftriaxone to 2 countries. The primary destination is KENYA receiving 97.8% of shipments worth $2.8M.
What Ceftriaxone Formulations Does ROYAL PHARMA 2011 LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| ROXONE 1GM: (CEFTRIAXONE INJECTION USP 1 | $867.7K | 21 |
| ROXONE-S-1.5 GM.(CEFTRIAXONE 1GM & SULBA | $63.8K | 12 |
| ROXONE 1G INJ CEFTRIAXONE INJECTION USP1000MG BATCH C5825019 MFG EXP DATE APR 25 MAR 28 | $52.6K | 2 |
| CEFTRIAXONE FOR INJECTION USP 1G VIREXIM 1g INJECTION | $50.0K | 1 |
| CEFTRIAXONE FOR INJECTION USP 1G VIREXIM1G INJECTION (OTHER DETAILS AS PER INVOICE) | $50.0K | 1 |
| ROXONE 1G INJ CEFTRIAXONE INJECTION USP1000MG BATCH C5825018 MFG EXP DATEMAR 25 FEB 28 | $49.7K | 2 |
| CEFTRIAXONE FOR INJECTION USP 1G VIREXIM 1G INJECTION | $41.6K | 2 |
| ROXONE-S- 1.5 gm Ceftriaxone 1gm & Sulb | $35.0K | 8 |
| ROXONE 1G INJ CEFTRIAXONE INJECTION USP1000MG BATCH C5825017 MFG EXP DATE MAR 25 FEB 28 | $30.1K | 1 |
| ROXONE 1G INJ(CEFTRIAXONE INJECTION USP1000MG) (B.NO C5824013 MFG DT: MAR-24,EXP DT: FEB-27) | $30.1K | 3 |
ROYAL PHARMA 2011 LIMITED imports 123 distinct Ceftriaxone formulations from India. The top formulation is ROXONE 1GM: (CEFTRIAXONE INJECTION USP 1 with 21 shipments worth $867.7K.
Who Are the Top Buyers of Ceftriaxone from India and How Much Does ROYAL PHARMA 2011 LIMITED Import?
India exported $32.1M worth of Ceftriaxone through 11,257 shipments from 850 suppliers to 162 countries, serving 2,555 buyers globally. ROYAL PHARMA 2011 LIMITED imports $2.9M of this total, accounting for 2.4% of India's Ceftriaxone exports with 226 shipments from KENYA. This is verified from 226 customs shipment records covering 123 distinct formulations.
What Is the Average Order Value for ROYAL PHARMA 2011 LIMITED's Ceftriaxone Imports?
ROYAL PHARMA 2011 LIMITED's average Ceftriaxone order value is $12.9K per consignment, based on 226 shipments totaling $2.9M. ROYAL PHARMA 2011 LIMITED is based in KENYA and ranks #1 among all Ceftriaxone importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Ceftriaxone to ROYAL PHARMA 2011 LIMITED?
ROYAL PHARMA 2011 LIMITED sources Ceftriaxone from 3 verified Indian suppliers: INNOVA CAPTAB LIMITED ($2.7M, 94.2%), EAST AFRICAN INDIA OVERSEAS ($141.6K, 4.9%), SAKAR HEALTHCARE LIMITED ($25.8K, 0.9%). This is based on 226 customs records.
How Does ROYAL PHARMA 2011 LIMITED Compare to Other Ceftriaxone Importers?
ROYAL PHARMA 2011 LIMITED ranks #1 among 2,555 Ceftriaxone importers from India with a 2.4% market share. The top 3 importers are ROYAL PHARMA 2011 LIMITED ($6.8M), AUROVIDA FARMACEUTICA, SA DE CV, ($4.8M), AL JABAL DRUGS & MEDICAL APPLIANCES ($3.8M). ROYAL PHARMA 2011 LIMITED processed 226 shipments from KENYA.
About ROYAL PHARMA 2011 LIMITED
ROYAL PHARMA 2011 LIMITED imports 2 products worth $8.4M. Beyond Ceftriaxone, top products include Artesunate. View the complete ROYAL PHARMA 2011 LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ceftriaxone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ceftriaxone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ROYAL PHARMA 2011 LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ROYAL PHARMA 2011 LIMITED's capped import value divided by total capped export value for Ceftriaxone across all Indian exporters.
- 5.Verified Records: This page is backed by 226 individual customs records matching ROYAL PHARMA 2011 LIMITED importing Ceftriaxone, covering 123 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 2,555+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ceftriaxone Import Data for ROYAL PHARMA 2011 LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for ROYAL PHARMA 2011 LIMITED's Ceftriaxone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ROYAL PHARMA 2011 LIMITED
Full Company Profile →
2 products · $8.4M total trade · 2 categories
ROYAL PHARMA 2011 LIMITED × Ceftriaxone
Verified from customs records
Company Overview
Top Products by ROYAL PHARMA 2011 LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ROYAL PHARMA 2011 LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ceftriaxone. For current order-level data, contact TransData Nexus.